Read the First Edition of The Lens, a new magazine by LSI arrow
Panelists discuss the role of bioconvergence in medtech innovation at LSI USA 2024

Dec 23, 2024

Bioconvergence: Breaking Down Silos in Disruptive Innovation

Bioconvergence—the interdisciplinary fusion of biology, engineering, and technology—is redefini...

Read More next
Panelists discuss methods for driving adoption of surgical robotics at LSI USA 2024

Dec 22, 2024

Driving the Adoption of Surgical Robotics in Healthcare

The future of surgical robotics is evolving rapidly, driven by technological innovation, shifting economic ...

Read More next
Panelists discuss AR and VR in healthcare at LSI USA 2024
Dec 18, 2024

Adoption of AR and VR in Healthcare: Tailwinds and Headwinds
next
Panelists discuss the future of data driven healthcare solutions at LSI USA 2024.
Dec 12, 2024

Data-Driven Healthcare Solutions: Monetization and Adoptability
next
Panelists discuss the importance of diversity in medtech founding teams at LSI USA 2024
Dec 6, 2024

Importance of Diversity in Medtech Founding Teams: A Data-Driven Case
next
Panelists discuss the role of digital technologies in healthcare at LSI USA 2024
Dec 3, 2024

Digital Technologies in Healthcare: Insights from Integra
next
Panelists discuss the growth of ambulatory surgery centers (ASCs) at LSI USA 2024
Nov 27, 2024

Ambulatory Surgery Centers: The Role of Robotics
next
Dave Hickey discussing medtech trends at LSI USA 2024.
Nov 27, 2024

Medtech Trends: Fireside Chat with Dave Hickey of BD Life Sciences
next
Panelists discuss the role of medtech partnerships at LSI USA 2024
Nov 22, 2024

Medtech Partnerships: How Can Major Device Companies Collaborate with the Startup Ecosystem?
next
Panelists at LSI USA 2024 discuss Israel’s medical technology ecosystem
Nov 19, 2024

Israel’s Medical Technology Ecosystem: A Culture of Innovation
next
Advent of AI What Will it Take to Drive True Adoption in Clinical Workflows
Nov 14, 2024

Adoption of AI in Healthcare: Adoption in Clinical Workflows
next
20 03 24_LSI_DAY_2_(ADAM) 0384
Nov 6, 2024

FDA Breakthrough Device Designation: ROI and Considerations With Shifts in Coverage
next